|
|
|
|
|
|
 | |
| President and Chief Medical Officer |
|
| Dr. Vijai Kumar has joined Excel Life Sciences from Neeman Medical International, Inc where he served as the first President and CEO. Prior to that, Dr Kumar worked as Medical Director, Sandoz and Regional Director, Asia for The Upjohn Company, where he was responsible for submitting NDAs for more than 20 drugs. Dr. Kumar has over 31 years experience in Global Drug Development, Strategic Relationship building, Business Development and various other aspects of clinical research and the pharmaceutical industry. He has served as a Member of the expert committee constituted by the Drugs Controller General (India) to develop GCP Guidelines in India and as a member of the Board of Governors for the Institute of Clinical Research, India. Dr Kumar has personally been involved in the conduct of over 200 clinical trials in various therapeutic areas such as, Infectious Disease, Neuropsychiatry, Cardiovascular Disorders, Metabolism and Rheumatology in Asia, Europe and the USA and has presented numerous papers on various aspects of clinical research across the globe. Dr Kumar holds an M.D. in Internal Medicine and an M.B.B.S. from Armed Forces Medical College, Pune. |
|
|
 | |
| Dan |
McDonald |
| Vice President Business Development |
Dan has over 10 years of industry experience working with biopharmaceutical companies assisting them with their patient recruitment and site selection strategies and connecting sites with sponsors. Prior to joining ELS Dan served as Sr. Vice President of Strategic Development for D. Anderson & Company, a leading provider of global patient recruitment and retention services. Dan oversaw the business development team at DAC and was also responsible in helping set strategic direction for the company and developing new products and services.
The majority of Dan’s career in the industry was spent at Thomson CenterWatch, where he worked for nearly 9 years, the last 3 as the General Manager of that business. Dan also had organizational responsibility for Thomson NEIRB an independent institutional review board. Dan oversaw strategic planning and all day-to-day operations of the CenterWatch business for Thomson Healthcare and also was in charge of Sales and Marketing for Thomson Clinical Trials Solutions. He also oversaw the development and publication of several articles and strategic planning reports focused on the rapid growth of clinical research in emerging markets, primarily India, Central & Eastern Europe and China.
Mr. McDonald has conducted over 40 presentations at industry conferences and meetings, and he has conducted workshops and sessions on patient recruitment. He is a member of the DIA Clinical Research Special Interest Area Community. He is has been published numerous times in industry trade magazines and journals and has authored chapters in several books on patient recruitment and clinical trial registration. |
|
|
 | |
|
Mohit was most recently the General Manager, New Product and Platforms for American Express where he led a global servicing team based out of the US, Canada and India. Previously, he was the Co-Founder and Interim Chief Executive Officer of Workadia. Before Workadia, Mohit had been at American Express for over 10 years, most recently as Vice President in its Interactive Business Development group, where he was the founding member and business leader for Workadia, which was spun off from within American Express. He played a key role in transforming the corporate travel industry from a manual labor-intensive operation to an online, highly automated and efficient environment.
His experience in leveraging technology and labor arbitrage to reduce operating costs and accelerate product development led him to found Excel Life Sciences, which helps customers accelerate drug development and improves patient care and satisfaction, while lowering costs for pharmaceutical companies, hospitals and medical research organizations. In addition, Mohit also wants to focus on the humanitarian aspect of bringing leading lines of treatment to a patient population that does not necessarily have access to healthcare. This humanitarian aspect is an integral part of the Excel Life Sciences mission. Mohit holds a Bachelor's degree in Business from University of Allahabad, India and a Master of Science from the University of Massachusetts, Amherst. |
|
|
 | |
|
| In the last ten years, Carl has been the senior financial executive of a number of tech start-ups in the Chicago area, either as the in-house CFO or a consulting CFO. These firms have been in a range of industries from consulting to software to opto-electronics and healthcare. Previously, Carl had spent over ten years in various financial and strategic roles in the US and Europe at Global 100 manufacturing firms. His roles included merger and acquisition due diligence on several transactions ranging from $10 to $300 million, developing the business case for a number of joint ventures, and subsequently moving two of those JV?s from start-up to profitability as the financial executive. Carl holds a BA in Economics and an MBA in Finance from the University of Illinois. |
|
|
|
|
|
|
|
Site Map | Copyright © 2006-2007 excellifesciences.com
|
|
|
